Table 1.
Characteristic | No. (%) of Patient Visitsb |
---|---|
Observation Period | |
2009–2011 | 588,791,594 (61) |
2007–2008 | 375,839,802 (39) |
Age (years) | |
Mean (SE) | 53.9 (0.23) |
Age Group | |
≥65 | 299,032,423 (31) |
45–64 | 351,209,142 (36) |
20–44 | 314,389,831 (33) |
Sex | |
Female | 587,394,025 (61) |
Male | 377,237,371 (39) |
Race | |
Other | 33,516,436 (5) |
African-American | 99,604,070 (14) |
Caucasian | 602,374,076 (82) |
Ethnicity | |
Hispanic/Latino | 79,262,491 (11) |
Non-Hispanic/Latino | 630,345,157 (89) |
Region | |
Northeast | 189,690,837 (20) |
Midwest | 206,775,296 (21) |
West | 201,670,759 (21) |
South | 366,494,504 (38) |
MSA | |
Non-MSA | 120,846,147 (13) |
MSA | 843,785,249 (87) |
Insurance Status | |
Other | 98,736,670 (11) |
Medicaid | 88,374,398 (10) |
Medicare | 280,902,288 (30) |
Private Insurance | 461,730,141 (49) |
Setting Type | |
Hospital Emergency | 94,712,528 (10) |
Hospital Outpatient | 78,137,131 (8) |
Physician’s Office | 791,781,738 (82) |
Diuretic Use | |
Yes | 71,243,249 (7) |
No | 893,388,147 (93) |
Gout | |
Yes | 11,769,697 (1) |
No | 952,861,700 (99) |
MSA Metropolitan Statistical Area
aUnweighted, raw study sample size
bSurvey weighting and clusters accounted for reflecting unbiased, national annual estimates of visit occurrences for the portion of the population meeting the study inclusion/exclusion criteria